Zobrazeno 1 - 10
of 82
pro vyhledávání: '"C. Boaziz"'
Autor:
Jean-François Morère, E. Haddad, T. Bouillet, J.J. Mazeron, C. Boaziz, S. Piperno-Neuman, Jean-Luc Breau
Publikováno v:
Cancer/Radiothérapie. 1:121-131
Resume But de l'etude Determiner l'efficacite et la tolerance d'une chimiotherapie d'induction suivie d'une association concomitante de radiotherapie et chimiotherapie dans le traitement du cancer bronchique non a petites cellules de stade III et rec
Autor:
Jean-Marie Andrieu, J. M. Pavlovitch, V. Lucas, Jean-Marc Tourani, Eric Pujade-Lauraine, C. Varette, D. Larregain, D. Mayeur, E. Vuillemin, P. Grise, B. Dufour, E. Ecstein, C. Boaziz, M. Di Palma, S. Merran, M. Untereiner
Publikováno v:
Annals of Oncology. 7:525-528
Summary Background This multicenter phase II trial was conducted in order to evaluate the efficacy and toxicity of the subcutaneous route of administration of rIL-2 in the treatment of patients with metastatic renal cell carcinoma and to check whethe
Publikováno v:
European Journal of Nuclear Medicine. 22:177-180
A case of small cell lung carcinoma (SCLC) demonstrating uptake on functional indium-111 octreotide scintigraphy is presented. Technetium-99m hexakis-2-methoxyisobutylisonitrile (MIBI) scintigraphy clearly delineated an absence of radionuclide uptake
Publikováno v:
European Journal of Cancer. 32:1429-1431
To determine its usefulness, we evaluated 111In-DTPA-Octreotide (octreotide scintigraphy) in the initial staging of 19 patients with histologically proven small cell lung cancer (SCLC) and compared the results to those of conventional imaging. Images
Autor:
T, André, P, Colin, C, Louvet, E, Gamelin, O, Bouche, E, Achille, N, Colbert, C, Boaziz, P, Piedbois, N, Tubiana-Mathieu, A, Boutan-Laroze, M, Flesch, V, Billiau, M, Buyse, A, Gramont
Publikováno v:
Seminars in oncology. 28(1 Suppl 1)
The aim of this randomized open-label study was to compare a bimonthly with a monthly regimen of 5-fluorouracil (5-FU) and leucovorin for the adjuvant treatment of colon and high-rectum adenocarcinoma. The bimonthly regimen was administered for 2 con
Publikováno v:
Annales de medecine interne. 151(4)
Gemcitabine, a deoxycytidine analog, is used to treat solid tumors, like non-small-cell lung carcinoma. The most commonly reported adverse effects are reversible and generally not fatal. However, among the five cases of acute respiratory distress syn
Autor:
J M, Tourani, C, Jaillon-Abraham, V, Lucas, Y, Chrétien, D, Mayeur, M, Di Palma, C, Boaziz, P, Grise, C, Varette, J M, Pavlovitch, D, Larregain, E, Ecstein, M, Untereiner, J M, Andrieu
Publikováno v:
Bulletin du cancer. 84(4)
We report a french experience of subcutaneous administration of interleukin-2 in treatment of patients with metastatic renal cell carcinoma. Thirty-nine patients with metastatic renal cell carcinoma were included in the study. During the 10-week indu
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 1(2)
To determine the efficacy and safety of induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of stage III non-small cell lung cancer and whether the response to induction chemotherapy can predict the response to subsequen
Autor:
J M, Tourani, P, Grise, V, Lucas, D, Mayeur, B, Dufour, M, Di Palma, C, Boaziz, J M, Pavlovitch, E, Pujade-Lauraine, D, Larregain, M, Untereiner
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 11(5)
Autor:
J M, Tourani, V, Lucas, D, Mayeur, B, Dufour, M, DiPalma, C, Boaziz, P, Grise, C, Varette, J M, Pavlovitch, E, Pujade-Lauraine, D, Larregain, E, Ecstein, M, Untereiner, E, Vuillemin, S, Merran, J M, Andrieu
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 7(5)
This multicenter phase II trial was conducted in order to evaluate the efficacy and toxicity of the subcutaneous route of administration of rIL-2 in the treatment of patients with metastatic renal cell carcinoma and to check whether an increased cumu